| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2011.02.017 |
| P698 | PubMed publication ID | 21397305 |
| P50 | author | Diane C. Bodurka | Q56600503 |
| David Gershenson | Q57167281 | ||
| Anais Malpica | Q69964105 | ||
| Kathleen M. Schmeler | Q89994549 | ||
| P2093 | author name string | Charlotte C Sun | |
| Michael T Deavers | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data | Q30939883 | ||
| Histopathologic grading of ovarian carcinoma: a review and proposal | Q33819296 | ||
| Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy | Q33968475 | ||
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations | Q34129787 | ||
| Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma | Q34626854 | ||
| Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum | Q34729698 | ||
| Serous psammocarcinoma of the ovary: a case report and review of literature. | Q35979273 | ||
| Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges | Q36294505 | ||
| Primary psammocarcinoma of the peritoneum | Q36412956 | ||
| Primary peritoneal serous psammocarcinoma with recurrent disease and metastasis: a case report and review of the literature | Q36707905 | ||
| Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. | Q36753706 | ||
| Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction | Q36924865 | ||
| New insights into the pathogenesis of serous ovarian cancer and its clinical impact | Q37119411 | ||
| Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention | Q37125079 | ||
| Primary psammocarcinoma of the ovary or peritoneum | Q37539588 | ||
| Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy | Q38134731 | ||
| Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential | Q38333986 | ||
| Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor). | Q39638363 | ||
| Observer variation in histologic classification of malignant and borderline ovarian tumors | Q39715820 | ||
| Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary | Q40301883 | ||
| A new histologic grading index in ovarian carcinoma | Q43561712 | ||
| Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases | Q43770804 | ||
| Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary | Q44456289 | ||
| Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. | Q46016693 | ||
| Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. | Q50655226 | ||
| Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. | Q51842388 | ||
| Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. | Q53337533 | ||
| Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. | Q53355871 | ||
| Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. | Q53383109 | ||
| Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. | Q53609842 | ||
| Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. | Q54685505 | ||
| Peritoneal mesothelioma | Q67556355 | ||
| Serous surface carcinoma of the peritoneum: A clinicopathologic study of 22 cases | Q67653114 | ||
| The ovarian mesothelioma | Q68796920 | ||
| Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases | Q69626773 | ||
| Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects | Q70136217 | ||
| Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma | Q71447480 | ||
| Ovarian involvement by serous surface papillary carcinoma | Q72000178 | ||
| Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma | Q72693859 | ||
| Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma | Q73144573 | ||
| Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer | Q74195164 | ||
| Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system | Q77068469 | ||
| Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status | Q77102021 | ||
| Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer | Q77333448 | ||
| Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential | Q77451184 | ||
| Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report | Q78459287 | ||
| Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma | Q79825860 | ||
| Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum | Q79862089 | ||
| Grading ovarian serous carcinoma using a two-tier system | Q79934949 | ||
| Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study | Q80028132 | ||
| Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma | Q80340138 | ||
| Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas | Q80843829 | ||
| Serous psammocarcinoma of the ovary: an unusual finding | Q80952846 | ||
| Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant | Q83636947 | ||
| P433 | issue | 3 | |
| P921 | main subject | peritoneal carcinoma | Q1816041 |
| P304 | page(s) | 482-486 | |
| P577 | publication date | 2011-03-11 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Low-grade serous primary peritoneal carcinoma | |
| P478 | volume | 121 |
| Q51160917 | Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience. |
| Q34528553 | Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms. |
| Q38367063 | CT features of low grade serous carcinoma of the ovary |
| Q37332490 | Clinical implications of using molecular diagnostics for ovarian cancers |
| Q50324389 | Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum |
| Q35947034 | Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor. |
| Q36750622 | Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum. |
| Q37747641 | Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review |
| Q40344519 | Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer |
| Q36305409 | Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases |
| Q45817225 | Quantification of ER/PR expression in ovarian low-grade serous carcinoma |
| Q40349757 | Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine. |
| Q55078149 | Role of tumor microenvironment in ovarian cancer pathobiology. |
| Q36768921 | Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study |
| Q38702245 | Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer. |
| Q38096241 | The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. |
| Q38516707 | When is it safe to omit surgery in primary peritoneal cancer with small volume disease? |
Search more.